Longevity BS, Breakthroughs and What Comes Next
In Part Two of my conversation with Dr Steven Lu, Everlab’s co-founder and Chief Medical Officer, we unpack what’s actually worth measuring, which treatments show real promise, what’s still experimental and what the future of preventative healthcare could look like.
And why, when it comes to optimising our health, we should be problem-centric, not solution-centric.
We dive into:
What keeps Steven up at night as Everlab grows and expands internationally.
What’s actually worth measuring: From Lp(a), a genetically influenced cardiovascular risk marker, to body composition, and the tests Steven…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.